AVM Biotechnology Inc
Quick facts
Marketed products
- Proton pump inhibitor · Gastroenterology
Proton pump inhibitors block the hydrogen/potassium ATPase enzyme in gastric parietal cells, reducing gastric acid secretion.
Phase 2 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about AVM Biotechnology Inc
What are AVM Biotechnology Inc's marketed drugs?
Top marketed products include Proton pump inhibitor.
Related
- Proton pump inhibitor · Gastroenterology
- Sector hub: All tracked pharma companies